Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_assertion type Assertion NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_head.
- NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_provenance.
- NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_assertion evidence source_evidence_literature NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_provenance.
- NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_assertion SIO_000772 17504987 NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_provenance.
- NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_assertion wasDerivedFrom befree-2016 NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_provenance.
- NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_assertion wasGeneratedBy ECO_0000203 NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_provenance.